Megan Seyboth
Associate Director, Revenue Management
Expertise:
Megan has more than nine years of experience in the life sciences industry, specializing in Government Pricing (GP). She lead’s EVERSANA’s GP team and has a large range of experience in all areas related to GP calculations and reporting including but not limited enrollment into the Government Programs, calculations for AMP, BP, ASP, and NFAMP, and FSS Contracting including contract solicitations, contract modifications, and Public Law. She has worked with small, mid-size, and large pharmaceutical companies with both branded and generic products to understand industry best practices.
Articles by Megan Seyboth
The Evolution of the 340B Rebate Model: Maintaining Patient Access while Minimizing Duplicate Discounts
The 340B program has struggled with implementing effective oversight of the covered entities since the program was established in 1992. Diversion and duplicate discounts are the primary issues that manufacturers face. Diversion typically happens when a 340B drug is dispensed to a non-340B patient and duplicate discounts typically happen when a product receives a 340B […]